StockVS

Colgate-Palmolive Company (CL) 股票分析

防御性消费

Colgate-Palmolive Company

$89.85

$-0.76 (-0.84%)

最后更新: 2026年5月26日

价格走势

最新新闻

新闻由第三方来源提供。不构成投资建议。

分析

公司概述

Colgate-Palmolive Company engages in the manufacturing and sale of consumer products within the United States and international markets, operating primarily through two distinct segments focused on oral, personal, home care, and pet nutrition. The company operates within the Consumer Defensive sector and the Household & Personal Products industry, classifications that denote its essential nature as a provider of daily hygiene and grooming necessities that maintain stable demand regardless of broader economic cycles. With a total market capitalization of $69.03B, annual revenue reaching $20.38B, and an employee base of 33,600, the entity demonstrates significant scale and operational footprint in the global consumer goods landscape. These valuation and revenue metrics collectively indicate that Colgate-Palmolive holds a substantial position in its industry, commanding a large market share that allows for pricing power and resilience against inflationary pressures typical in the household products sector.

财务健康

The company reported a total revenue of $20.38B and net income of $2.13B over the trailing twelve months, while EBITDA stands at $4.87B. The substantial gap between the $20.38B revenue and the $2.13B net income reveals a cost structure where approximately 90% of revenue is consumed by costs of goods sold, operating expenses, and taxes, leaving a relatively thin profit cushion before interest and other non-operating items. Free cash flow for the period is $3.08B, which signifies strong financial flexibility to fund capital expenditures, service debt obligations, and return capital to shareholders without relying on external financing. Operating margins are maintained at a robust 20.4%, while gross margins reach 60.1% and profit margins settle at 10.5%, indicating efficient production scale and effective cost control across the supply chain. The balance sheet shows $1.40B in cash against $8.55B in total debt, resulting in a debt-to-equity ratio of 2343.56, which suggests a highly leveraged capital structure relative to equity, though the high cash generation helps mitigate interest coverage risks. The current ratio is recorded at 0.83, indicating that the company's current assets are slightly less than its current liabilities, which points to a need for careful working capital management to meet short-term obligations. Return on Equity is an exceptionally high 497.5% and Return on Assets is 16.4%, metrics that reveal management's ability to generate significant returns on the capital invested, likely driven by the heavy use of financial leverage and the stable nature of its earnings base.

估值评估

The trailing twelve-month P/E ratio is 32.71, while the forward P/E is 20.87, implying that the market expects earnings growth to accelerate significantly in the future to justify the lower forward multiple compared to the current historical average. The price-to-book ratio is listed at 1284.18, a figure that indicates the market values the company at a massive premium over its net asset book value, reflecting the intangible value of brand equity rather than physical assets. Alternative valuation metrics such as the price-to-sales ratio of 3.39 and EV/EBITDA of 15.70 suggest that investors are pricing in strong future growth and dominance in a fragmented market, despite the high book value multiple. The 52-week high is $99.33 and the low is $74.55, and without a specific current share price provided in the facts, the trading range defines the volatility band within which the stock has operated over the past year. The beta value of 0.33 indicates that the stock exhibits very low volatility relative to the broader market, moving significantly less than the S&P 500 and offering a defensive characteristic that buffers portfolio value during periods of market downturns.

Growth & Income

Revenue growth year-over-year is 5.8%, while earnings growth is marked as N/A in the available data, suggesting that profitability is either stable or that specific earnings growth figures are not currently disclosed for comparison. Although specific earnings growth rates are unavailable, the positive revenue growth combined with the high return on equity implies that the company is effectively expanding its top line, potentially through price increases or volume gains in its global footprint. As a consistent dividend payer, the company offers a dividend yield of 2.5% with a payout ratio of 78.3%, which indicates that the majority of net income is distributed to shareholders, requiring careful monitoring to ensure sustainability given the high leverage. The overall growth and income profile presents a blend of steady, albeit modest, revenue expansion and a generous yield, characteristic of mature consumer staples companies that prioritize shareholder returns over aggressive reinvestment for hyper-growth.

同行比较

Colgate-Palmolive Company (CL) 在家庭与个人护理产品行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Colgate-Palmolive Company CL $71.90B 34.8
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Kenvue Inc. KVUE $33.58B 20.8

家庭与个人护理产品行业平均市盈率为29.9倍。Colgate-Palmolive Company的市盈率为34.8。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

公司简介以英文显示。

访问官网 →

关键指标

市值
$71.90B
市盈率
34.83
52周最高
$99.33
52周最低
$74.55
平均成交量
5.90M
Beta系数
0.30
股息率
2.36%

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
33,600